We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
No events to show.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
BeOne Medicines advances CLL paradigm with long-term Brukinsa data - grafa.com
BeOne Medicines advances CLL paradigm with long-term Brukinsa data grafa.com
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026 - Via TT
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026 Via TT
Number of shareholders of BeOne Medicines Ltd. Class A – SSE:688235 - TradingView
Number of shareholders of BeOne Medicines Ltd. Class A – SSE:688235 TradingView
BEONE MEDICINES (06160.HK) An Taisite Approved in Mainland China for Second-line Treatment of Small Cell Lung Cancer - AASTOCKS.com
BEONE MEDICINES (06160.HK) An Taisite Approved in Mainland China for Second-line Treatment of Small Cell Lung Cancer AASTOCKS.com
BEONE MEDICINES (06160.HK) An Taisite Approved in Mainland China for Second-line Treatment of Small Cell Lung Cancer - AASTOCKS.com
BEONE MEDICINES (06160.HK) An Taisite Approved in Mainland China for Second-line Treatment of Small Cell Lung Cancer AASTOCKS.com
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 05. | After market close (AMC) | — | — | — | $1.59B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0 | — | — | $1.12B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.36 | — | — | $2.68B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.27 | — | — | $1.68B | Reported |
No research actions to show.
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.